The hallmarks of Parkinson's disease
- PMID: 23663200
- DOI: 10.1111/febs.12335
The hallmarks of Parkinson's disease
Abstract
Since the discovery of dopamine as a neurotransmitter in the 1950s, Parkinson's disease (PD) research has generated a rich and complex body of knowledge, revealing PD to be an age-related multifactorial disease, influenced by both genetic and environmental factors. The tremendous complexity of the disease is increased by a nonlinear progression of the pathogenesis between molecular, cellular and organic systems. In this minireview, we explore the complexity of PD and propose a systems-based approach, organizing the available information around cellular disease hallmarks. We encourage our peers to adopt this cell-based view with the aim of improving communication in interdisciplinary research endeavors targeting the molecular events, modulatory cell-to-cell signaling pathways and emerging clinical phenotypes related to PD.
Keywords: Parkinson's disease; cellular hallmarks; environmental factors; genetic factors; systems biology; translational research.
© 2013 FEBS.
Similar articles
-
Dysfunction of dopamine homeostasis: clues in the hunt for novel Parkinson's disease therapies.FASEB J. 2013 Jun;27(6):2101-10. doi: 10.1096/fj.12-226852. Epub 2013 Mar 5. FASEB J. 2013. PMID: 23463698 Review.
-
Caenohabditis elegans in Parkinson's disease drug discovery: addressing an unmet medical need.Mol Interv. 2008 Dec;8(6):284-93. doi: 10.1124/mi.8.6.6. Mol Interv. 2008. PMID: 19144901 Review.
-
Alpha-synuclein and Parkinson's disease: a proteomic view.Expert Rev Proteomics. 2008 Apr;5(2):239-48. doi: 10.1586/14789450.5.2.239. Expert Rev Proteomics. 2008. PMID: 18466054 Review.
-
Genetics and iron in the systems biology of Parkinson's disease and some related disorders.Neurochem Int. 2013 Apr;62(5):637-52. doi: 10.1016/j.neuint.2012.11.015. Epub 2012 Dec 7. Neurochem Int. 2013. PMID: 23220386 Review.
-
Advances in the genetics of Parkinson's disease.Acta Pharmacol Sin. 2008 Jan;29(1):21-34. doi: 10.1111/j.1745-7254.2008.00731.x. Acta Pharmacol Sin. 2008. PMID: 18158863 Review.
Cited by
-
Implications of COVID-19 in Parkinson's disease: the purinergic system in a therapeutic-target perspective to diminish neurodegeneration.Purinergic Signal. 2024 Mar 9. doi: 10.1007/s11302-024-09998-7. Online ahead of print. Purinergic Signal. 2024. PMID: 38460075 Review.
-
Review of Phytochemical Potency as a Natural Anti-Helicobacter pylori and Neuroprotective Agent.Molecules. 2023 Oct 18;28(20):7150. doi: 10.3390/molecules28207150. Molecules. 2023. PMID: 37894629 Free PMC article. Review.
-
Parkinson's Neuropathology Puzzle: A Systematic Review Uncovering the Pathological Culprits Behind the Neurological Disease.Cureus. 2023 Aug 29;15(8):e44353. doi: 10.7759/cureus.44353. eCollection 2023 Aug. Cureus. 2023. PMID: 37664277 Free PMC article. Review.
-
Dysphagia in Parkinson Disease: Part I - Pathophysiology and Diagnostic Practices.Curr Phys Med Rehabil Rep. 2023 Jun;11(2):176-187. doi: 10.1007/s40141-023-00392-9. Epub 2023 Mar 28. Curr Phys Med Rehabil Rep. 2023. PMID: 37608845 Free PMC article.
-
Identification of novel immune-related biomarker and therapeutic drugs in Parkinson disease via integrated bioinformatics analysis.Medicine (Baltimore). 2023 Aug 4;102(31):e34456. doi: 10.1097/MD.0000000000034456. Medicine (Baltimore). 2023. PMID: 37543820 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
